Assessment of Peripheral Blood Indices in Patients with Papillary Thyroid Carcinoma
Keywords:
Papillary Thyroid Carcinoma, LMR, P-LCRAbstract
Background: The most prevalent thyroid cancer is papillary thyroid carcinoma (PTC), frequently has an optimistic prognosis. However, the need for basic and credible biomarkers to assist in distinguish between benign and malignant thyroid nodules is highlighted by concerns for overdiagnosis and overtreatment. Complete blood count (CBC)-derived peripheral blood cell indices have become promising markers of tumour behaviour and systemic inflammation.
Method: There were 63 participants in this case-control study: 10 healthy controls, 37 patients with benign thyroid nodules, and 16 patients with histopathologically confirmed PTC. Inflammatory and platelet-related indices, as well as the lymphocyte-to-monocyte ratio (LMR), were among the clinical, demographic, and CBC parameters that were examined. One-way ANOVA and chi-square tests were used for statistical comparisons; p < 0.05 was deemed statistically significant.
Result: Patients with PTC had a significantly higher frequency of lymph node metastases (p = 0.042). When compared to benign cases, patients with PTC had a significantly lower LMR and a significantly higher granulocyte percentage (p < 0.05). While the platelet-large cell ratio (P-LCR) did not significantly differ between groups, several CBC parameters, such as white blood cell subtypes and platelet indices, did.
Conclusion: Granulocyte percentage, platelet parameters, and LMR are among the peripheral blood cell indices that are correlated with papillary thyroid carcinoma and may be useful supplementary biomarkers for distinguishing benign from malignant thyroid nodules. To validate their clinical applicability, more prospective research is required.
References
Bellastella, G., Scappaticcio, L., Caiazzo, F., Tomasuolo, M., Carotenuto, R., Caputo, M., Arena, S., Caruso, P., Maiorino, M.I. and Esposito, K. (2022). Mediterranean diet and thyroid: an interesting alliance. Nutrients, 14(19), 4130. https://doi.org/10.3390/nu14194130
Yeh, S.J., Lin, C.Y., Li, C.W. and Chen, B.S. (2019). Systems biology approaches to investigate genetic and epigenetic molecular progression mechanisms for identifying gene expression signatures in papillary thyroid cancer. International Journal of Molecular Sciences, 20(10), 2536. https://doi.org/10.3390/ijms20102536
He, J., Tian, Z., Yao, X., Yao, B., Liu, Y. and Yang, J. (2020). A novel RNA sequencing-based risk score model to predict papillary thyroid carcinoma recurrence. Clinical & Experimental Metastasis, 37(2), 257–267.https://doi.org/10.1007/s10585-019-10011-4
4. Moon, S., Yi, K.H. and Park, Y.J. (2022). Risk of adverse pregnancy outcomes in young women with thyroid cancer: a systematic review and meta-analysis. Cancers, 14(10), 2382. https://doi.org/10.3390/cancers14102382
Haugen, B.R., Alexander, E.K., Bible, K.C., Doherty, G.M., Mandel, S.J., Nikiforov, Y.E., Pacini, F., Randolph, G.W., Sawka, A.M., Schlumberger, M., Schuff, K.G., Sherman, S.I., Sosa, J.A., Steward, D.L., Tuttle, R.M. and Wartofsky, L. (2016). 2015 American Thyroid Association management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer. Thyroid, 26(1), 1–133. https://doi.org/10.1089/thy.2015.0020
Lim, H., An, Y.M., Kim, K.H., Cho, H.J., Heo, J.I., Lee, H., Lee, J.M., Kim, J., Kim, S.W., Shin, J.H., Kim, J.H. and Lee, S.H. (2017). Papillary thyroid carcinoma: Epidemiology and genetics. International Journal of Medical Sciences, 14(10), 450–460. https://doi.org/10.7150/ijms.29935
Nikiforov, Y.E., Ohori, N.P., Rodriguez, J.M., Park, Y.I., Seethala, R.R. and Baloch, Z.W. (2015). Late-onset papillary thyroid carcinoma: A new entity? The American Journal of Surgical Pathology, 39(12), 1655–1662. https://doi.org/10.1097/PAS.0000000000000511
Papillary thyroid carcinoma. (2024). Radiopaedia.org. Available at: https://radiopaedia.org/articles/papillary-thyroid-carcinoma-1 (Accessed: 13 December 2025).
Vajpayee, N., Graham, S.S. and Bem, S. (2022). Basic examination of blood and bone marrow. In: McPherson, R.A. and Pincus, M.R. (eds.) Henry’s Clinical Diagnosis and Management by Laboratory Methods. 24th ed. Philadelphia, PA: Elsevier, Chapter 31.
Chen, X., Wang, H., Yu, L., Liu, J. and Sun, H. (2025). Correlation of multiple peripheral blood parameters with metastasis and invasion of papillary thyroid cancer: a retrospective cohort study. Endocrine. Springer.
Cheong, M.A., Loke, J.W.S. and Nagarajan, C. (2022). Haematological prehabilitation. In: Prehabilitation for Cancer Surgery. Springer
Gambardella C, Polistena A, Sanguinetti A, et al. Unintentional recurrent laryngeal nerve injuries following thyroidectomy: is it the surgeon who pays the bill? Int J Surg. 2017;41(Suppl 1):S55–S59. doi:10.1016/j.ijsu.2017.01.112
Conzo G, Polistena A, Calo PG, et al. Efficacy of combined treatment for anaplastic thyroid carcinoma: results of a multinstitutional retrospective analysis. Int J Surg. 2014;12(Suppl 1):S178–S182. doi:10.10 16/j.ijsu.2014.05.015
Liu JF, Ba L, Lv H, Lv D, Du JT, Jing XM, et al. Association between neutrophil-to-lymphocyte ratio and differentiated thyroid cancer: a meta-analysis. Sci Rep. 2016; 6:38551. https://doi.org/10.1038/ srep38551 PMID: 27941815
Yaylaci S, Tosun O, Sahin O, Genc AB, Aydin E, Demiral G, et al. Lack of Variation in Inflammatory Hematological Parameters between Benign Nodular Goiter and Papillary Thyroid Cancer. Asian Pac J Cancer Prev. 2016; 17:2321-3. https://doi.org/10.7314/apjcp.2016.17.4.2321 PMID: 27221938
el-Hag A, Clark RA. Immunosuppression by activated human neutrophils. Dependence on the myelo- peroxidase system. J Immunol. 1987; 139:2406-13. PMID: 2821114
Wang DS, Luo HY, Qiu MZ, Wang ZQ, Zhang DS, Wang FH, et al. Comparison of the prognostic values of various inflammation-based factors in patients with pancreatic cancer. Med Oncol. 2012; 29:3092- 100, https://doi.org/10.1007/s12032-012-0226-8 PMID: 22476808
Kao SC, Pavlakis N, Harvie R, Vardy JL, Boyer MJ, van Zandwijk N, et al. High blood neutrophil-to-lym- phocyte ratio is an indicator of poor prognosis in malignant mesothelioma patients undergoing systemic therapy. Clin Cancer Res. 2010; 16:5805-13. https://doi.org/10.1158/1078-0432.CCR-10-2245 PMID: 20956618
Yokota M, Katoh H, Nishimiya H, Kikuchi M, Kosaka Y, Sengoku N, et al. Lymphocyte-Monocyte Ratio Significantly Predicts Recurrence in Papillary Thyroid Cancer. J Surg Res. 2020; 246:535-43. https:// doi.org/10.1016/j.jss.2019.09.034 PMID: 31711613
Zhang L, Luo H, Wang L, Liu Y, Rui S, Wu Z, et al. Diagnostic and prognostic value of preoperative systemic inflammatory markers in anaplastic thyroid cancer. J Surg Oncol (2020) 122(5):897-905. doi: 10.1002/jso.26089
Katoh H, Watanabe M. Myeloid-derived suppressor cells and therapeutic strategies in cancer. Mediators Inflammation (2015) 2015:159269. doi: 10.1155/ 2015/159269
Ray-Coquard I, Cropet C, Van Glabbeke M, Sebban C, Le Cesne A, Judson I, et al. Lymphopenia as a prognostic factor for overall survival in advanced carcinomas, sarcomas, and lymphomas. Cancer Res (2009) 69(13):5383-91. doi: 10.1158/0008-5472.can-08-3845
Schumacher D, Strilic B, Sivaraj KK, Wettschureck N, Offermanns S. Platelet-derived nucleotides promote tumor-cell transendothelial migration and metastasis Via P2y2 receptor. Cancer Cell (2013) 24(1):130-7. doi: 10.1016/ j.ccr.2013.05.008
Wen W, Wu P, Li J, Wang H, Sun J, Chen H. Predictive values of the selected inflammatory index in elderly patients with papillary thyroid cancer. J Transl Med (2018) 16(1):261. doi: 10.1186/s12967-018-1636-y
Threatte GA. Usefulness of the mean platelet volume. Clin Lab Med (1993) 13(4):937-50. doi: 10.1016/S0272-2712(18)30418-9
Mangalpally KK, Siqueiros-Garcia A, Vaduganathan M, Dong JF, Kleiman NS, Guthikonda S. Platelet activation patterns in platelet size Sub-populations: Differential responses to aspirin in vitro. J Thromb Thrombolysis (2010) 30(3):251- 62. doi: 10.1007/s11239-010-0489-x
Osada J, Rusak M, Kamocki Z, Dabrowska MI, Kedra B. Platelet activation in patients with advanced gastric cancer. Neoplasma (2010) 57(2):145-50. doi: 10.4149/neo_2010_02_145
Wen W, Wu P, Li J, Wang H, Sun J, Chen H. Predictive Values of the Selected Inflammatory Index in Elderly Patients With Papillary Thyroid Cancer. J Transl Med (2018) 16(1):261. doi: 10.1186/s12967-018-1636-y
Threatte GA. Usefulness of the Mean Platelet Volume. Clin Lab Med (1993) 13(4):937-50. doi: 10.1016/S0272-2712(18)30418-9
Mangalpally KK, Siqueiros-Garcia A, Vaduganathan M, Dong JF, Kleiman NS, Guthikonda S. Platelet Activation Patterns in Platelet Size Sub-Populations: Differential Responses to Aspirin In Vitro. J Thromb Thrombolysis (2010) 30 (3):251-62. doi: 10.1007/s11239-010-0489-x
Dincel O, Bayraktar C. Evaluation of Platelet Indices as a Useful Marker in Papillary Thyroid Carcinoma. Bratisl Lek Listy (2017) 118(3):153-5. doi: 10.4149/ bll_2017_030
Alsweedan SA, Al-Shurman A, Mahmoud AS. Diagnostic Value of Platelet Indices in Children With Leukemia. J Pediatr Hematol Oncol (2008) 30 (12):953-5. doi: 10.1097/MPH.0b013e318182e7a9
Yokota M, Katoh H, Nishimiya H, Kikuchi M, Kosaka Y, Sengoku N, et al. Lymphocyte-Monocyte Ratio Significantly Predicts Recurrence in Papillary Thyroid Cancer. J Surg Res (2020) 246:535-43. doi: 10.1016/j.jss.2019. 09.034
Katoh H, Watanabe M. Myeloid-Derived Suppressor Cells and Therapeutic Strategies in Cancer. Mediators Inflamm (2015) 2015:159269. doi: 10.1155/ 2015/159269
